Biotechnology & Medical Research

Incyte Corp announces top-line results from RELIEF trial of Ruxolitinib in patients with Polycythemia Vera

Incyte Corp:Says top-line results from RELIEF, randomized, double-blind clinical trial designed to compare symptom improvement in 110 patients with polycythemia vera (PV) treated with ruxolitinib versus patients treated with hydroxyurea (HU).While positive trends were observed in favor of...

4:15pm EDT

Sangamo Biosciences Inc reaffirms FY 2014 revenue guidance

Sangamo Biosciences Inc:Expects that revenues will be in the range of $45 million to $50 million in FY 2014, inclusive of research funding and certain milestone payments from Shire and Biogen.FY 2014 revenue of $48 million - Thomson Reuters I/B/E/S.

4:02pm EDT

La Jolla Pharmaceutical announces pricing of underwritten offering of common stock

La Jolla Pharmaceutical Co:Prices underwritten offering of 4,800,000 shares of its common stock, offered at a price of $10.50 per share.La Jolla has granted the underwriters a 30-day option to purchase up to an additional 720,000 shares of common stock.Offering is expected to close on or about July...

9:14am EDT

SAGE Therapeutics announces closing of initial public offering

SAGE Therapeutics Inc:Closes its initial public offering of 5,750,000 shares of its common stock at a public offering price of $18.00 per share, before underwriting discounts.Company's common stock is listed on The NASDAQ Global Market under the symbol "SAGE.".J.P. Morgan Securities LLC and Goldman,...

6:30am EDT

Expansion & New Markets


  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.

Analyst Research

Report Title Price
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research
Provider: Edison Investment Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.